Chioma N Izzi-Engbeaya

No ORCID on file · 2 papers in corpus

observational 2025

Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank

BMC gastroenterology ·doi:10.1186/s12876-025-04079-4

INTRODUCTION: People with metabolic-dysfunction associated steatotic liver disease (MASLD) had higher risk of extrahepatic multimorbidity, and fibrosis is the strongest prognostic factor for mortality in MASLD. This study aimed to investiga…

other 2025

The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort

The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgaf342

CONTEXT: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one third of the world's population, but its associations with extrahepatic multimorbidity and mortality remain unclear. OBJECTIVE: This study aimed to estim…